Dedicated to improving the health and well-being of people around the world.

We drive innovative treatments, science, and technology to address patient needs in the critical areas of psychiatry & neurology, oncology, urology, women's health, rare disease, and cell & gene therapy.

Learn More

Discovering Sumitomo Pharma America (SMPA)

This icon shows three arrows pointing upwards, to represent growth and momentum.

Innovation growth engine

Drug discovery, development, and commercialization must become faster and more efficient to address humanity’s health needs. SMPA embodies the bold promise of combining technology and life-sciences expertise to measurably improve patient outcomes.
This icon shows three rows of drug development programs and symbols to depict their milestones of development. To represent active clinical development.

Diverse pipeline

Our preclinical and clinical programs span numerous modalities and indications where patient needs remain high or unmet.
This icon shows a symbol of the human brain, where one half is the brain, and the other half is a data circuit. To represent technology-driven solutions.

Fueling breakthroughs

Delivering patient-first solutions sooner through a technology-driven approach.


The latest from SMPA